Birchview Capital’s Neurocrine Biosciences NBIX Stock Holding History

Birchview Capital’s Portfolio NBIX Stock Details NBIX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.89M	Buy	30,940 +700	+2%	+$88K	3.86%	6
2025 Q1	$3.34M	Hold	30,240	–	–	2.9%	6
2024 Q4	$4.13M	Hold	30,240	–	–	3.36%	6
2024 Q3	$3.48M	Sell	30,240 -12,000	-28%	-$1.38M	3.02%	7
2024 Q2	$5.82M	Sell	42,240 -35,000	-45%	-$4.82M	5.37%	4
2024 Q1	$10.7M	Hold	77,240	–	–	8.68%	2
2023 Q4	$10.2M	Hold	77,240	–	–	7.96%	2
2023 Q3	$8.69M	Sell	77,240 -7,000	-8%	-$788K	7.38%	3
2023 Q2	$7.94M	Hold	84,240	–	–	5.95%	3
2023 Q1	$8.53M	Hold	84,240	–	–	6.68%	3
2022 Q4	$10.1M	Sell	84,240 -1,000	-1%	-$119K	7.11%	3
2022 Q3	$9.05M	Hold	85,240	–	–	6.37%	3
2022 Q2	$8.31M	Sell	85,240 -4,000	-4%	-$390K	6.04%	3
2022 Q1	$8.37M	Buy	89,240 +40	+0%	+$3.75K	6.02%	2
2021 Q4	$7.6M	Buy	89,200 +9,000	+11%	+$767K	4.9%	5
2021 Q3	$7.69M	Hold	80,200	–	–	5.23%	5
2021 Q2	$7.81M	Hold	80,200	–	–	4.67%	4
2021 Q1	$7.8M	Hold	80,200	–	–	4.63%	4
2020 Q4	$7.69M	Buy	80,200 +2,200	+3%	+$211K	4.43%	5
2020 Q3	$7.5M	Hold	78,000	–	–	5.01%	5
2020 Q2	$9.52M	Buy	78,000 +4,000	+5%	+$488K	5.75%	5
2020 Q1	$6.41M	Buy	74,000 +19,000	+35%	+$1.64M	5.68%	3
2019 Q4	$5.91M	Hold	55,000	–	–	4.3%	3
2019 Q3	$4.96M	Hold	55,000	–	–	3.3%	3
2019 Q2	$4.64M	Hold	55,000	–	–	2.82%	4
2019 Q1	$4.85M	Hold	55,000	–	–	3.04%	4
2018 Q4	$3.93M	Buy	55,000 +7,000	+15%	+$500K	3.72%	3
2018 Q3	$5.9M	Sell	48,000 -2,000	-4%	-$246K	3.81%	3
2018 Q2	$4.91M	Sell	50,000 -2,400	-5%	-$236K	3.34%	3
2018 Q1	$4.35M	Hold	52,400	–	–	2.86%	3
2017 Q4	$4.07M	Hold	52,400	–	–	2.38%	4
2017 Q3	$3.21M	Buy	52,400 +27,200	+108%	+$1.67M	1.66%	4
2017 Q2	$1.16M	Hold	25,200	–	–	0.61%	7
2017 Q1	$1.09M	Hold	25,200	–	–	0.61%	10
2016 Q4	$975K	Hold	25,200	–	–	0.6%	11
2016 Q3	$1.28M	Hold	25,200	–	–	0.74%	9
2016 Q2	$1.15M	Hold	25,200	–	–	0.83%	10
2016 Q1	$997K	Buy	25,200 +2,000	+9%	+$79.1K	0.71%	11
2015 Q4	$1.31M	Buy	23,200 +13,500	+139%	+$763K	0.76%	11
2015 Q3	$386K	Buy	+9,700	New	+$386K	0.25%	26